A forthcoming biography of Queen Elizabeth II has revealed that Prince Philip, the Duke of Edinburgh, quietly lived with inoperable pancreatic cancer for nearly eight years before his passing. This surprising disclosure, serialised exclusively in the Mail on Sunday, sheds light on a condition notoriously difficult to detect and with one of the lowest survival rates among cancers.
Diagnosis and Defiance of Prognosis
Biographer Hugo Vickers reports in Queen Elizabeth II that Prince Philip was diagnosed with pancreatic cancer in June 2013 during an 11-day hospital stay. Despite the grim prognosis associated with the disease, where many patients succumb within six months, the Duke survived until April 2021, just two months shy of his 100th birthday. His death certificate listed 'old age' as the cause, masking the underlying battle.
Vickers describes poignant moments from his final days, including how Prince Philip used a Zimmer frame to pour himself a beer in the Oak Room at Windsor Castle the night before he died. The following morning, he reportedly took a bath, expressed feeling unwell, and passed away peacefully.
Understanding Pancreatic Cancer Risk Factors
Prince Philip's story underscores the critical importance of awareness regarding pancreatic cancer and its risk factors. Early recognition can sometimes improve outcomes, though the disease remains a formidable challenge.
Genetic and Familial Links: Approximately five to ten percent of pancreatic cancer cases occur in individuals with a family history. Risk escalates if a first-degree relative is affected or if diagnoses occur at a young age. Inherited gene mutations, such as BRCA1, BRCA2, and PALB2, are also implicated, though they are more commonly associated with breast, ovarian, and prostate cancers.
Age and Demographic Shifts: Age is a significant risk factor, with nearly half of cases diagnosed in people over 75. However, incidence is rising more rapidly among younger age groups, particularly women, potentially due to improved detection and increases in obesity, type 2 diabetes, and smoking.
Lifestyle and Environmental Influences
Smoking and Nicotine Products: Smoking accounts for about one in five pancreatic cancers, with cigarettes, cigars, pipes, and chewing tobacco all elevating risk. Emerging research on snus, nicotine pouches popular among young men, suggests they may also contribute. Quitting smoking can reduce risk to that of a non-smoker after two decades.
Obesity and Related Conditions: Roughly ten percent of cases are linked to being overweight or obese. Excess abdominal fat can lead to insulin resistance, straining the pancreas and potentially fostering cancer development. Obesity also heightens the risk of type 2 diabetes, which is associated with higher pancreatic cancer rates.
Alcohol and Chronic Pancreatitis: Sustained heavy drinking, defined as three or more units daily, can cause chronic pancreatitis, a known precursor to pancreatic cancer. Recent guidance from the UK's MHRA has highlighted potential links between weight-loss injections and pancreatitis, though no direct cancer connection has been established.
Dietary Factors: Some studies indicate that high consumption of red and processed meats may slightly increase risk, especially in men. Cooking methods like grilling or barbecuing can produce harmful chemicals, though evidence remains inconclusive and warrants further research.
Symptoms and Detection Challenges
Pancreatic cancer is often termed a 'silent killer' due to its subtle early symptoms, which can include unexplained weight loss, upper abdominal or back pain, jaundice, loss of appetite, and digestive changes. New-onset diabetes in older adults may also serve as an early warning sign.
Currently, there is no general population screening for pancreatic cancer. However, high-risk individuals, such as those with strong family histories or genetic syndromes, may be offered regular imaging or genetic testing to aid in early detection.
Prince Philip's prolonged survival against the odds highlights both the resilience possible in rare cases and the urgent need for greater public awareness and research into this devastating disease.
